David A. Siegel Eli Lilly & CO Transaction History

Two Sigma Advisers, LP

$43.8 Billion
Q2 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Eli Lilly & CO stock. As of the latest transaction made, Two Sigma Advisers, LP holds 751,900 shares of LLY stock, worth $637 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares

751,900

Previous 601,900 24.92%

Holding current value

$637 Million

Previous $468 Million 45.38%

% of portfolio

1.55%

Previous 1.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $109 Million - $136 Million	150,000 Added 24.92%	751,900 $681 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $95.6 Million - $128 Million	161,400 Added 36.64%	601,900 $468 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $129 Million - $152 Million	-245,400 Reduced 35.78%	440,500 $257 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $275 Million - $379 Million	633,100 Added 1199.05%	685,900 $368 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $44.5 Million - $59.5 Million	-126,800 Reduced 70.6%	52,800 $24.8 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $44.1 Million - $51.8 Million	-142,100 Reduced 44.17%	179,600 $61.7 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $75.1 Million - $87.6 Million	233,700 Added 265.57%	321,700 $118 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $96.1 Million - $110 Million	-324,100 Reduced 78.65%	88,000 $28.5 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $183 Million - $215 Million	-656,900 Reduced 61.45%	412,100 $134 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $166 Million - $206 Million	-707,000 Reduced 39.81%	1,069,000 $306 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $56.1 Million - $69.6 Million	-249,500 Reduced 12.32%	1,776,000 $491 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $442 Million - $544 Million	1,995,800 Added 6719.87%	2,025,500 $468 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $2.64 Million - $3.41 Million	-14,616 Reduced 32.98%	29,700 $6.82 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $24.5 Million - $31.7 Million	-149,100 Reduced 77.09%	44,316 $8.28 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $247 Million - $327 Million	-1,893,900 Reduced 90.73%	193,416 $32.7 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $44.3 Million - $51.2 Million	-302,800 Reduced 12.67%	2,087,316 $309 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $137 Million - $165 Million	1,003,200 Added 72.33%	2,390,116 $392 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $32 Million - $39.6 Million	-268,700 Reduced 16.23%	1,386,916 $192 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $38.6 Million - $47.8 Million	360,700 Added 27.86%	1,655,616 $218 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $27.6 Million - $30 Million	258,300 Added 24.92%	1,294,916 $145 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $36.2 Million - $42.3 Million	327,100 Added 46.1%	1,036,616 $115 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $20.1 Million - $23.7 Million	180,516 Added 34.12%	709,516 $92.1 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $34.5 Million - $38.7 Million	-326,095 Reduced 38.14%	529,000 $61.2 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $38.9 Million - $48.6 Million	-453,100 Reduced 34.64%	855,095 $91.8 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $37.3 Million - $42.8 Million	-492,500 Reduced 27.35%	1,308,195 $112 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $113 Million - $133 Million	1,518,468 Added 538.03%	1,800,695 $139 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $6.63 Million - $7.11 Million	80,932 Added 40.21%	282,227 $23.8 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $15.5 Million - $17.2 Million	201,295	201,295 $17.2 Million

Others Institutions Holding LLY

# of Institutions

3,905

Shares Held

765M

Call Options Held

6.35M

Put Options Held

7.95M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $805B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account